Miles White

Type: Person
Name: Miles White (Miles D. White)
Title: Chairman and chief executive officer
Organization: Abbott Laboratories
Date of Birth: 1955
Place of Birth: Minneapolis, Minnesota
Nationality: United States
Fact Sheet: Biography for Miles White
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

That tough talk on corporate tax dodges? Never mind

Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois.Credit: BloombergA Pentagon contract announced this week sheds new light on the controversy over corporate inversions, and how tough the federal ... [Published Crains ChicagoBusiness - Aug 20 2014]
First reported Aug 05 2014 - Updated Aug 06 2014 - 1 reports

But Dad, I Was Only Doing My Fiduciary Duty

Fights between Congress and companies are nothing new. Companies want to maximize profits; Congress often feels like that's at the detriment of the country. But the squabbles don't often involve family members. Turns out the Democratic Senator from West ... [Published Motley Fool - Aug 05 2014]
First reported Aug 02 2014 - Updated Aug 02 2014 - 1 reports

Close loopholes that let U.S. firms avoid taxes by using inversions

It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion.Endearing, ... [Published Los Angeles Times - Aug 02 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Abbott CEO chides critics of corporate inversions | Medtech Wall Street news for the week of July 21, 2014

by Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; ... [Published MassDevice - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Abbott would gain big time if it made like AbbVie

Never shy, Abbott Laboratories CEO Miles White has waded right into the growing controversy over U.S. companies claiming foreign residence for tax purposes.“The raging debate about these decisions has been absurd,” Mr. White wrote in a Wall Street Journal ... [Published Crains ChicagoBusiness - Jul 23 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Abbott CEO defends inversions amid corporate exodus furor

by Abbott chairman & CEO Miles White chides critics of corporate inversions as Capitol Hill mulls legislation to strip tax benefits for companies that shift their headquarters overseas.Abbott  (NYSE: ABT ) chairman & CEO Miles White took to the media ... [Published MassDevice - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 2 reports

Abbott sells developed market generics business to Mylan

:36 in Medical Company Restructures Abbott has announced the sale of its developed markets branded generics pharmaceuticals business to Mylan as part of a wider strategic refocusing. The company has exchanged the business unit for equity ownership of ... [Published Zenopa - Jul 17 2014]
First reported Jul 16 2014 - Updated Jul 17 2014 - 2 reports

Abbott making 'progress' repairing Fonterra botulism scare damage

Abbott Laboratories' CEO believes the company has  “recovered about as well"  as it could have in the year since the Fonterra WPC botulism scare that led it to recall infant formula in China, Vietnam, and Saudi Arabia.Speaking on Abbott's Q2 conference ... [Published Nutra Ingredients USA - Jul 17 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 2 reports

Abbott Labs Gets No Respect Despite a Healthy Second Quarter

07/16/14 - 03:50 PM EDTNEW YORK ( TheStreet ) -- Abbott Laboratories ( ABT ) is the proverbial diamond in the rough. It's a healthy company that recently sold its overseas generic pharmaceuticals business to Mylan Laboratories ( MYL ) for $5.3 billion ... [Published TheStreet.com - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 2 reports

Abbott Shares Rise On Bottom-Line Beat And Lifted Full-Year Forecast

Shares of Abbott Laboratories, a $60 billion global healthcare company, are on the rise in early Wednesday trading after the company reported second quarter earnings results that were higher than anticipated thanks to strong sales of its medical diagnostic ... [Published Forbes.com - Jul 16 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 5 reports

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Following a weekend of rumors and speculation, USA-based generics major Mylan (Nasdaq: MYL) and health care firm Abbott Laboratories (NYSE: ABT) this morning confirmed they have entered into a definitive agreement whereby Mylan will acquire Abbott's non-US ... [Published Pharma Letter - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 2 reports

Abbott Labs Sharpens Device Focus with $5 Billion Sale

Maybe they should change their name to Abbott Engineering.Abbott Park, IL–based Abbott Laboratories continues to divest itself of pharmaceutical holdings as it focuses more attention on medical devices and diagnostics, with the latest deal involving the ... [Published QMED - Jul 15 2014]

Quotes

"that wasn't something anybody anticipated, it wasn't something anybody wanted to happen, including fonterra. but when it happens, it does set you back a bit" White told analysts
"we're ahead of our expectations through the first half of the year and are raising our eps guidance range as we continue to shape the company for long-term growth" said Miles White, chairman and chief executive of Abbott

More Content

All (50) | News (48) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
That tough talk on corporate tax dodges? Never ... [Published Crains ChicagoBusiness - Aug 20 2014]
Obama Donors Embrace Corporate Inversions He Cr... [Published Bloomberg - Aug 13 2014]
But Dad, I Was Only Doing My Fiduciary Duty [Published Motley Fool - Aug 05 2014]
Close loopholes that let U.S. firms avoid taxes... [Published Los Angeles Times - Aug 02 2014]
Leaders of Chicago healthcare: 70 people to know [Published Beckers Hospital Review - Aug 01 2014]
Jon Stewart takes on 'corporate inversion' [Published Daily Kos - Jul 31 2014]
Abbott CEO chides critics of corporate inversio... [Published MassDevice - Jul 24 2014]
Abbott would gain big time if it made like AbbVie [Published Crains ChicagoBusiness - Jul 23 2014]
Morning 10: CPS budget 'gimmick' | Illinois ven... [Published Crains ChicagoBusiness - Jul 23 2014]
JEFF JACOBY Inverters aren’t deserters [Published Boston Globe - Jul 23 2014]
Transcript: Friday, July 18, 2014 [Published NBR.com - Jul 21 2014]
Tax inversion not cheating or unpatriotic: Abbo... [Published Pharma Times - Jul 21 2014]
Abbott, Fonterra Team To Build Milk Farm In China [Published China Retail News - Jul 20 2014]
AbbVie successfully plays the tax game [Published Crains ChicagoBusiness - Jul 18 2014]
Abbott CEO defends inversions amid corporate ex... [Published MassDevice - Jul 18 2014]
Look for alternatives to rein in inversions — C... [Published Politico - Jul 18 2014]
Abbott sells developed market generics business... [Published Zenopa - Jul 17 2014]
Abbott making 'progress' repairing Fonterra bot... [Published Nutra Ingredients USA - Jul 17 2014]
Abbott Labs 2nd-quarter revenues rise 1.9% [Published Pharma Letter - Jul 17 2014]
Medtronic could face legislative pushback in ta... [Published FierceMedicalDevices - Jul 16 2014]
Will Abbott Rule the Diagnostics Market by 2019? [Published Medical Device & Diagnostic Industry - Jul 16 2014]
Abbott Labs Gets No Respect Despite a Healthy S... [Published TheStreet.com - Jul 16 2014]
Abbott Labs Gets No Respect Despite a Healthy S... [Published The Street Latest - Jul 16 2014]
China to get new dairy hub [Published CHINAdaily - Jul 16 2014]
Abbott Laboratories' (ABT) CEO, Miles White on ... [Published Seeking Alpha - Jul 16 2014]
Abbott med tech revenues up slightly as company... [Published FierceMedicalDevices - Jul 16 2014]
Sanofi Talked With Abbott, Mylan, Funds on Matu... [Published Washington Post - Jul 16 2014]
Abbott Asset Sale Gives Ammunition for Perrigo [Published Bloomberg - Jul 16 2014]
Abbott beats profit estimate, infant formulas r... [Published Sharenet - Jul 16 2014]
Abbott reports meager medical device sales grow... [Published MassDevice - Jul 16 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.